| 8.55 Data as of May 23 |  +0.12 / +1.42%Today’s Change | 6.92 Today|||52-Week Range 17.48 | -23.57% Year-to-Date |
| The Gap Fill Play Starring Spectrum Pharma May 22 / StockTwits | The 5 Dumbest Things on Wall Street This Week: May 17 May 17 / TheStreet.com |
| Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma May 17 / TheStreet.com | Spectrum Pharma Reports 1Q Loss - Analyst Blog May 14 / Zacks.com |
| Previous close | 8.43 |
| Today’s open | 8.35 |
| Day’s range | -- - -- |
| Volume | 774,292 |
| Average volume (3 months) | 1,467,098 |
| Market cap | $506.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +73.81% |
| Earnings growth (this year) | -114.50% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +38.73% |
| P/E ratio | 12.0 |
| Price/Sales | 2.45 |
| Price/Book | 1.78 |
| Today’s change | Today’s % change | |
|---|---|---|
| SGNTSagent Pharmaceutica... | -0.06 | -0.33% |
| SNTASynta Pharmaceutical... | -0.08 | -1.08% |
| EBSEmergent BioSolution... | +0.01 | +0.07% |
| ECYTEndocyte Inc | +0.23 | +1.67% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $267.7M |
| Annual profit (last year) | $94.5M |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Rajesh C. Shrotriya, MD |
Chief Operating Officer & Executive Vice President Kenneth Joseph Keller, MBA |
Corporate headquarters Henderson, Nevada |
.
